Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Feb 13, 2025

SELL
$45.39 - $50.36 $292,765 - $324,822
-6,450 Closed
0 $0
Q4 2023

Feb 13, 2025

SELL
$43.13 - $54.79 $21,521 - $27,340
-499 Reduced 7.18%
6,450 $321 Million
Q3 2023

Feb 13, 2025

SELL
$50.95 - $55.2 $26,392 - $28,593
-518 Reduced 6.94%
6,949 $373 Million
Q4 2022

Feb 13, 2025

SELL
$38.86 - $48.55 $29,961 - $37,432
-771 Reduced 9.36%
7,467 $362 Million
Q3 2022

Feb 13, 2025

SELL
$37.22 - $100.5 $4,317 - $11,658
-116 Reduced 1.39%
8,238 $313 Million
Q2 2022

Feb 13, 2025

SELL
$48.99 - $57.46 $25,817 - $30,281
-527 Reduced 5.93%
8,354 $418 Million
Q1 2022

Feb 13, 2025

SELL
$48.48 - $53.65 $67,096 - $74,251
-1,384 Reduced 13.48%
8,881 $456 Million
Q4 2021

Feb 13, 2025

SELL
$47.07 - $52.35 $5,271 - $5,863
-112 Reduced 1.08%
10,265 $514 Million
Q3 2021

Feb 13, 2025

SELL
$47.89 - $53.12 $54,355 - $60,291
-1,135 Reduced 9.86%
10,377 $500 Million
Q2 2021

Feb 13, 2025

SELL
$49.36 - $54.25 $40,327 - $44,322
-817 Reduced 6.63%
11,512 $606 Million
Q1 2021

Feb 13, 2025

BUY
$45.46 - $50.51 $37,459 - $41,620
824 Added 7.16%
12,329 $610 Million
Q4 2020

Feb 13, 2025

BUY
$45.3 - $51.62 $44,439 - $50,639
981 Added 9.32%
11,505 $559 Million
Q4 2019

Feb 13, 2025

BUY
$44.25 - $50.86 $7,611 - $8,747
172 Added 1.66%
10,524 $528 Million
Q3 2019

Feb 13, 2025

BUY
$40.34 - $46.64 $29,972 - $34,653
743 Added 7.73%
10,352 $480 Million
Q2 2019

Feb 13, 2025

SELL
$40.43 - $44.3 $11,279 - $12,359
-279 Reduced 2.82%
9,609 $416 Million
Q1 2019

Feb 13, 2025

BUY
$40.83 - $45.43 $403,727 - $449,211
9,888 New
9,888 $438 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $137B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Ategra Capital Management, LLC Portfolio

Follow Ategra Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ategra Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ategra Capital Management, LLC with notifications on news.